Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8398)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang XX, Wang LF, Jin L, Li YY, Hao SL, Shi YC, Zeng QL, Li ZW, Zhang Z, Lau GK, Wang FS. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors. World J Gastroenterol 2015; 21(12): 3554-3563 [PMID: 25834320 DOI: 10.3748/wjg.v21.i12.3554] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3554.htm |
| Number | Citing Articles |
| 1 |
Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85688-3
|
| 2 |
Hannes Hagström. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?. Current Hepatology Reports 2017; 16(2): 152 doi: 10.1007/s11901-017-0343-0
|
| 3 |
Hyun-seok Kim, Hashem B. El-Serag. The Epidemiology of Hepatocellular Carcinoma in the USA. Current Gastroenterology Reports 2019; 21(4) doi: 10.1007/s11894-019-0681-x
|
| 4 |
Sylvia Drazilova, Ingrid Babinska, Jakub Gazda, Monika Halanova, Martin Janicko, Branislav Kucinsky, Dominik Safcak, Dominika Martinkova, Lucia Tarbajova, Anna Cekanova, Peter Jarcuska. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia. International Journal of Public Health 2020; 65(5): 683 doi: 10.1007/s00038-020-01391-6
|
| 5 |
Lifeng Wang, Christopher L. Bowlus, Fu-Sheng Wang, M. Eric Gershwin. Biliary Disease. 2017; : 129 doi: 10.1007/978-3-319-50168-0_8
|
| 6 |
Hannes Hagström. Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 2017; 31(5): 537 doi: 10.1016/j.bpg.2017.09.003
|
| 7 |
Cristina Micali, Ylenia Russotto, Grazia Caci, Manuela Ceccarelli, Andrea Marino, Benedetto Maurizio Celesia, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV. Infectious Disease Reports 2022; 14(1): 43 doi: 10.3390/idr14010006
|
| 8 |
Christine C. Hsu, Kris V. Kowdley. The Effects of Alcohol on Other Chronic Liver Diseases. Clinics in Liver Disease 2016; 20(3): 581 doi: 10.1016/j.cld.2016.02.013
|
| 9 |
Michael Chew, Christopher L. Bowlus. Primary biliary cholangitis: Diagnosis and treatment. Liver Research 2018; 2(2): 81 doi: 10.1016/j.livres.2018.03.004
|
| 10 |
Yamini Natarajan, Aylin Tansel, Parth Patel, Kingsley Emologu, Richa Shukla, Zeeshan Qureshi, Hashem B. El-Serag, Aaron P. Thrift, Fasiha Kanwal. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2021; 66(7): 2439 doi: 10.1007/s10620-020-06498-7
|
| 11 |
Ziqian Xu, Wan Tang, Qiaoling Xie, Xinyu Cao, Mengni Zhang, Xiaoxun Zhang, Jin Chai. Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3/GSDMD signaling in mice. Experimental Cell Research 2023; 432(2): 113781 doi: 10.1016/j.yexcr.2023.113781
|
| 12 |
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
|
| 13 |
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Archiv 2021; 479(6): 1131 doi: 10.1007/s00428-021-03183-6
|
| 14 |
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment. Cancer Medicine 2019; 8(3): 1054 doi: 10.1002/cam4.1998
|
| 15 |
Costin Teodor Streba, Cristin Constantin Vere, Ion Rogoveanu, Nicu Dan Florescu. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.78328
|
| 16 |
Meaghan Phipps, Alexandra Livanos, Averill Guo, Sydney Pomenti, Jonathan Yeh, Lara Dakhoul, Heather Burney, Carla Kettler, Hao Liu, Ethan Miller, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Julia Wattacheril. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. American Journal of Gastroenterology 2020; 115(9): 1486 doi: 10.14309/ajg.0000000000000643
|
| 17 |
Hai-Chun Zhang, Rong-Fei Hu, Ting Zhu, Ling Tong, Qiu-Qin Zhang. Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators. World Journal of Gastroenterology 2016; 22(22): 5276-5284 doi: 10.3748/wjg.v22.i22.5276
|
| 18 |
Ana Lleo, Giu-Qiang Wang, Merrill Eric Gershwin, Gideon M Hirschfield. Primary biliary cholangitis. The Lancet 2020; 396(10266): 1915 doi: 10.1016/S0140-6736(20)31607-X
|
| 19 |
Sainan Bian, Li Wang, Yunyun Fei, Suying Liu, Hua Chen, Fengchun Zhang. The clinical and laboratory features associated with cancer in patients with primary biliary cholangitis: a longitudinal survey–based study. Clinical Rheumatology 2021; 40(8): 3311 doi: 10.1007/s10067-021-05657-z
|
| 20 |
Honglin Xu, Ziyan Wu, Futai Feng, Yongzhe Li, Shulan Zhang. Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization study. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1055953
|
| 21 |
Wenfang Peng, Bojin Xu, Haiping Zhou, Juan Du, Xiaoxu Ge, Shan Huang. Causal effects of autoimmune diseases on thyroid cancer: a two-sample Mendelian randomization study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1401458
|
| 22 |
Aylin Tansel, Lior H. Katz, Hashem B. El-Serag, Aaron P. Thrift, Mayur Parepally, Mohammad H. Shakhatreh, Fasiha Kanwal. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2017; 15(8): 1207 doi: 10.1016/j.cgh.2017.02.006
|
| 23 |
Na Zeng, Weijia Duan, Sha Chen, Shanshan Wu, Hong Ma, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia. Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis. Hepatology International 2019; 13(6): 788 doi: 10.1007/s12072-019-09984-x
|
| 24 |
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang. A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population. Cancer Medicine 2024; 13(9) doi: 10.1002/cam4.7230
|
| 25 |
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(4): 2194 doi: 10.3390/ijms25042194
|
| 26 |
Eirini I. Rigopoulou, George N. Dalekos. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers 2021; 13(5): 1023 doi: 10.3390/cancers13051023
|
| 27 |
Alexander M. Sy, Raphaella D. Ferreira, Binu V. John. Hepatocellular Carcinoma in Primary Biliary Cholangitis. Clinics in Liver Disease 2022; 26(4): 691 doi: 10.1016/j.cld.2022.06.011
|
| 28 |
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria, Nathalia Mota de Faria Gomes, Elze Maria Gomes Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone Muniz Carvalho Fernandes da Cunha, Marlone Cunha-Silva, Liliana Sampaio Costa Mendes, Claudia Alexandra Pontes Ivantes, Liana Codes, Valéria Ferreira de Almeida e Borges, Fabio Heleno de Lima Pace, Mario Guimarães Pessoa, Izabelle Venturini Signorelli, Gabriela Perdomo Coral, João Galizzi Filho, Aline Lopes Chagas, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome. Annals of Hepatology 2023; 28(4): 101105 doi: 10.1016/j.aohep.2023.101105
|
| 29 |
Qingshui Huang, Shuai Chu, Xiaofeng Yin, Xiaobin Yu, Chunmin Kang, Xin Li, Yurong Qiu. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis. The Tohoku Journal of Experimental Medicine 2016; 240(4): 269 doi: 10.1620/tjem.240.269
|
| 30 |
Blaire E. Burman, Manan A. Jhaveri, Kris V. Kowdley. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis. Clinics in Liver Disease 2017; 21(4): 709 doi: 10.1016/j.cld.2017.06.005
|
| 31 |
M. Carbone, A. Gerussi, V. Cardinale, N. Cazzagon, V. Cossiga, A. Lleo, G. Marrone, M. Marzioni, A. Moschetta, L. Muratori, C. Rigamonti, U. Vespasiani-Gentilucci, M. Fraquelli, V. Calvaruso. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis. Digestive and Liver Disease 2024; 56(9): 1461 doi: 10.1016/j.dld.2024.05.002
|